SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Schöbitz B, De Kloet RE, Holsboer F. Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Prog Neurobiol 1994;44:397432.
  • 2
    Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol 1992;263:C116.
  • 3
    Bartfai T, Shultzberg M. Cytokines in neuronal cell types. Neurochem Int 1993;22:43544.
  • 4
    Hopkins SJ, Rothwell NJ. Cytokines and the nervous system, I: expression and recognition. Trends Neurosci 1995;18:838.
  • 5
    Minami M, Kuraishi Y, Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun 1991;176:5938.
  • 6
    Yabuuchi K, Minami M, Katsumata S, et al. In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain. Mol Brain Res 1993;20:15361.
  • 7
    Gahring LC, White SH, Skradski SL, et al. Interleukin-1β in the brain is induced by audiogenic seizure. Neurobiol Dis 1997;3:2639.DOI: 10.1006/nbdi.1996.0123
  • 8
    Eriksson C, Winblad B, Schultzberg M. Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. Mol Brain Res 1998;58:195208.
  • 9
    Plata-Salaman CR, Ilyin SE, Turrin NP, et al. Kindling modulates the IL-1β system, TNF-α,TGF-β1 and neuropeptide mRNA in specific brain regions. Mol Brain Res 2000;75:24854.
  • 10
    De Bock F, Dornand J, Rondouin G. Release of TNF in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 1996;7:11259.
  • 11
    Sheng JG, Boop FA, Mrak RE, et al. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α immunoreactivity. J Neurochem 1994;63:187279.
  • 12
    Kanemoto K, Kawasaki J, Miyamato T, et al. Interleukin(IL)-1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47:5714.DOI: 10.1002/1531-8249(200005)47:5<571::aid-ana3>3.3.co;2-1
  • 13
    Lundkvist J, Sundgren-Andersson AK, Tingsborg S, et al. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist. Am J Physiol 1999;276:R64451.
  • 14
    Vezzani A, Conti M, De Luigi A, et al. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999;19:505465.
  • 15
    De Simoni MG, Perego C, Ravizza T, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12:262333.
  • 16
    Schwarzer C, Williamson JM, Lothman EW, et al. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 1995;74:1683.
  • 17
    Lothman EW, Bertram EH, Bekenstein JW, et al. Self-sustaining limbic status epilepticus induced by continuous hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res 1989;3:10719.
  • 18
    Racine RJ. Modification of seizure activity by electrical stimulation, II: motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:28194.
  • 19
    Vezzani A, Moneta D, Conti M, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000;97:115349.
  • 20
    Murray B, Alessandrini A, Cole AJ, et al. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc Natl Acad Sci U S A 1998;95:1197580.
  • 21
    Vereker E, O'Donnell E, Lynch MA. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 2000;20:68119.
  • 22
    Dinarello CA. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J Biol Regul Homeost Agents 1997;11:91103
  • 23
    Ye ZC, Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 1996;7:21815.
  • 24
    Zeise ML, Espinoza J, Morales P, et al. Interleukin-1β does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res 1997;768:3414.
  • 25
    Wang S, Cheng Q, Malik S, et al. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABAA) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 2000;292:497504.
  • 26
    Rothwell NJ. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci 1991;12:4306.
  • 27
    Katsuki H, Nakai S, Hirai Y, et al. Interleukin-1beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 1990;181:3236.
  • 28
    Bellinger FP, Madamba S, Siggins GR. Interleukin-1beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 1993;628:22734.
  • 29
    Cunningham AJ, Murray CA, O'Neill LAJ, et al. Interleukin-1beta (IL-1beta) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 1996;203:1720.
  • 30
    Coogan A, O'Connor JJ. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β. Neuroreport 1997;8:210710.